DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine-Reference-Cited by-同舟云学术

DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine

Published:2022-11-02 Issue:4 Volume:13 Page:649-669
ISSN:1878-5085
Container-title:EPMA Journal
language:en
Short-container-title:EPMA Journal

Author:

Zhang Guodong,Wang Zhengdan,Song Pingping,Zhan Xianquan^ORCID

Funder

the Shandong First Medical University Talent Introduction Funds

Shandong First Medical University High-level Scientific Research Achievement Cultivation Funding Program

the Shandong Provincial Natural Science Foundation

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Health Policy,Drug Discovery

Link

https://link.springer.com/content/pdf/10.1007/s13167-022-00300-6.pdf

Reference174 articles.

1. Sung H, Ferlay J, Siegel RL. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

2. Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5(3):288–300. https://doi.org/10.21037/tlcr.2016.06.07.

3. Tamura T, Kurishima K, Nakazawa K, Kagohashi K, Ishikawa H, Satoh H, Hizawa N. Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mole Clin Oncol. 2015;3(1):217–21. https://doi.org/10.3892/mco.2014.410.

4. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 2009;23(7):781–3. https://doi.org/10.1101/gad.1787609.

5. Cheng T, Zhan X. Pattern recognition for predictive, preventive, and personalized medicine in cancer. EPMA J. 2017;8(1):51–60. https://doi.org/10.1007/s13167-017-0083-9.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach;EPMA Journal;2024-05-24

2. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells;Frontiers in Immunology;2024-03-14

3. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach;EPMA Journal;2024-03-04

4. Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies;EPMA Journal;2023-07-31

5. Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine;EPMA Journal;2023-05-22